Stratos Wealth Partners, Ltd. United Therapeutics Corp Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$101.4 - $128.73 $71,791 - $91,140	-708 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$113.81 - $129.46 $80,577 - $91,657	708 New	708 $91,000
Q2 2018 Aug 13, 2018	SELL	$101.14 - $118.31 $81,215 - $95,002	-803 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$107.21 - $151.94 $1,179 - $1,671	-11 Reduced 1.35%	803 $90,000
Q4 2017 Feb 09, 2018	BUY	$118.58 - $151.28 $96,524 - $123,141	814	814 $120,000

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.